Epalrestatas
Epalrestatas CAS Nr .: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat vartojamas periferinei neuropatijai (tirpimui, skausmui), vibracinei parestezijai ir širdies anomalijoms, susijusioms su diabetu, užkirsti, pagerinti ir gydyti. SPECIFIKACIJA
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat vartojamas periferinei neuropatijai (tirpimui, skausmui), vibracinei parestezijai ir širdies anomalijoms, susijusioms su diabetu, užkirsti, pagerinti ir gydyti. SPECIFIKACIJA
| P rodukto pavadinimas | Epalrestatas |
| CAS | 82159-09-9 |
| MF: | C15H13NO3S2 |
| MW: | 319.4 |
Parašykite savo pranešimą čia ir atsiųskite mums
